JP2004505635A5 - - Google Patents

Download PDF

Info

Publication number
JP2004505635A5
JP2004505635A5 JP2002517821A JP2002517821A JP2004505635A5 JP 2004505635 A5 JP2004505635 A5 JP 2004505635A5 JP 2002517821 A JP2002517821 A JP 2002517821A JP 2002517821 A JP2002517821 A JP 2002517821A JP 2004505635 A5 JP2004505635 A5 JP 2004505635A5
Authority
JP
Japan
Prior art keywords
trichosanthin
protein
tcs
amino acid
mtcs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002517821A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004505635A (ja
JP4418155B2 (ja
Filing date
Publication date
Priority claimed from CN 00119553 external-priority patent/CN1283630A/zh
Priority claimed from CNB011031026A external-priority patent/CN1152051C/zh
Application filed filed Critical
Publication of JP2004505635A publication Critical patent/JP2004505635A/ja
Publication of JP2004505635A5 publication Critical patent/JP2004505635A5/ja
Application granted granted Critical
Publication of JP4418155B2 publication Critical patent/JP4418155B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002517821A 2000-08-02 2001-07-18 変異天花粉蛋白 Expired - Fee Related JP4418155B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN 00119553 CN1283630A (zh) 2000-08-02 2000-08-02 一种天花粉蛋白突变体及制备方法
CNB011031026A CN1152051C (zh) 2000-08-02 2001-01-18 一种天花粉蛋白突变体及制备方法
PCT/CN2001/001178 WO2002012537A2 (en) 2000-08-02 2001-07-18 Mutant trichosanthin

Publications (3)

Publication Number Publication Date
JP2004505635A JP2004505635A (ja) 2004-02-26
JP2004505635A5 true JP2004505635A5 (enExample) 2009-02-26
JP4418155B2 JP4418155B2 (ja) 2010-02-17

Family

ID=25739487

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002517821A Expired - Fee Related JP4418155B2 (ja) 2000-08-02 2001-07-18 変異天花粉蛋白

Country Status (6)

Country Link
US (1) US7157552B2 (enExample)
EP (1) EP1307480B1 (enExample)
JP (1) JP4418155B2 (enExample)
CN (2) CN1152051C (enExample)
AU (1) AU2002214919A1 (enExample)
WO (1) WO2002012537A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1312175C (zh) 2004-09-09 2007-04-25 北京大学 天花粉蛋白突变体及其编码基因
CN101469016B (zh) * 2007-12-29 2011-09-07 上海交通大学医学院 天花粉蛋白衍生肽及其应用
US20140179677A1 (en) * 2010-12-29 2014-06-26 Akita University Therapeutic agent for ectopic pregnancy
CN110412264A (zh) * 2019-08-01 2019-11-05 临沂大学 一种用于天花粉真伪鉴定的双抗夹心酶联免疫试剂盒及其使用鉴别方法
CN112501190A (zh) * 2021-02-04 2021-03-16 广东药科大学附属第一医院 一种重组质粒、美白剂、其制备方法及相关应用
CN114317466B (zh) * 2022-01-04 2023-10-27 中山大学附属第三医院 一种突变acc1蛋白及其用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128460A (en) 1989-04-04 1992-07-07 Genelabs Incorporated Recombinant trichosanthin and coding sequence
US5077390A (en) 1989-04-04 1991-12-31 Genelabs, Incorporated Purified trichosanthin and method of preparation
JPH06506949A (ja) 1991-04-15 1994-08-04 ニューヨーク ユニバシテイ カロからの抗hivタンパク質、tap29、そのためのdnaコード化およびその治療学的使用
US5541110A (en) * 1994-05-17 1996-07-30 Bristol-Myers Squibb Cloning and expression of a gene encoding bryodin 1 from Bryonia dioica

Similar Documents

Publication Publication Date Title
Hollister Marijuana and immunity
TWI251492B (en) Pharmaceutical composition containing botulinum neurotoxin and novel use thereof
Brodie et al. Possible interrelationship between release of brain norepinephrine and serotonin by reserpine
DE69731357T2 (de) Funktionelles antigenfragment von tetanustoxin und tetanusvakzine
US6420141B1 (en) Anti-HIV immunogens (toxoids), preparation methods and use for preventing and treating aids
EP1322338A4 (en) COMPOSITIONS AND METHODS OF USING A CAPSID PROTEIN FROM VARIOUS FLAVIVIRUS AND PESTIVIRUS
FI81262C (fi) Foerfarande foer isolering av ett med adenylat-cyklas-aktivitet associerat antigenpreparat ur bakterien bordetella pertussis.
NO20011304L (no) Fremgangsmåte for å nedregulere osteoprotegerin ligand aktivitet
Tong et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis
HUP0104717A2 (hu) Készítmények és eljárások petefészekrák terápiájára és diagnózisára
Horner et al. Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity
ATE290545T1 (de) Inhibitoren des interleukin-1beta konvertierenden enzyms
Kruse‐Jarres Inhibitors: our greatest challenge. Can we minimize the incidence?
CA1188218A (en) PURIFIED ANTINEOPLASTIC FRACTIONS AND METHODS OF TREATMENT OF NEOPLASMS
EP0527753A1 (en) CLEANING A PERTUSSIS EXTERIOR MEMBRANE PROTEIN.
ABDULLAH et al. Distribution of glycoprotease activity and the glycoprotease gene among serotypes of Pasteurella haemolytica
Kagnoff et al. Celiac sprue: correlation with murine T cell responses to wheat gliadin components.
Katz et al. Lysine methylation of mitochondrial ATP synthase subunit c stored in tissues of dogs with hereditary ceroid lipofuscinosis
JP2004505635A5 (enExample)
EP1556513A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES MEDIATED BY THE HUMANE PAPILLOMA VIRUS
Abramsky et al. Neuritogenic and encephalitogenic properties of the peripheral nerve basic proteins
WO2004043373A3 (en) Precursor n-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
DE3685837T2 (de) Hepatitis-a-virus-impfstoff.
Tleugabulova et al. Evidence for the denaturation of recombinant hepatitis B surface antigen on aluminium hydroxide gel
WO1993007172A1 (fr) Vaccin de sous-unite contre les infections a neisseriameningitidis et sous-unites correspondantes a l'etat purifie